Silver Book Fact

It is imperative to weigh costs of implementing new technologies for predicting onset of Alzheimer’s disease through biomarkers and delaying onset earlier against the potential benefits of improving health. Overall the study finds that the value of increased longevity through these potential innovations will greatly exceed the rising costs of health care.


  • Innovative Medical Research
  • Future Value

Related Facts

  • Stopping the Progress of Parkinson’s Would Save >$440,000 per Person
  • Spinal Cord Stimulation Shows Improvements for Parkinson’s Patients
  • Early Gene Therapy Studies Show Promise for Parkinson’s Disease
  • An Alzheimer’s treatment breakthrough that slowed disease progression and began to show effects in 2015, would reduce Medicaid costs for people with the disease by $62 billion–from the expected $178…  
  • Galantamine, a cholinesterase inhibitor, delays Alzheimer’s patients’ need for full-time care, with overall cost savings estimated between $323 and $4,256 per patient.